Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I find your interest in me rather concerning. Why are you so interested in how many shares i have? Shouldn't you be more interested in your own portfolio?
You remind me of an escape i made from an ex-girlfriend of mine around 40-years-ago (as my dear father said at the time "your lucky you didn't marry that one"). And I'm far to long in the tooth to have another stalker!
I'm not sure if you have any knowledge about investments, although i note that you only really post on GDR - hardly an indication of a balanced portfolio!?
OK - after this can you please stop posting about me and mind your own business.
I have some FTSE stocks, Equity funds, pensions, properties, and AIM stocks (all shares in ISA's and SIPP's as far as possible). I'm no expert by any means, although to negate getting overexposed in one investment i never have more than 20% of my pot in one investment. Additionally, i am realistic enough to know that AIM stocks are high risk. More of a speed boat that can accelerate fast but could also sink, as opposed to a FTSE stock being a larger, more stable ship.
Occasionally, as some say you get caught "holding the baby" and need to make a decision - do i sell at a loss or average down - rightly or wrongly i've averaged down here in the hope that things come good - and i believe they will. Anyone who thinks investing in AIM is all roses is in for a rude awakening. Am i stubborn, or should i have taken a hit and moved on - maybe - time will tell.
Now - i hope this helps you Stockprick.
If i need to break things down any further i'll need a blackboard and chalk.
Apologies fellow stockholders and here's to better days ahead.
I think the market is quite naturally suspicious of GDR at the moment, however, if Specialist Commissioning or news of an American FDA partner were to drop this share would be a whole different ball game. Also expecting news of extra take up of the MTRNR-1 in the UK and the possibility of overseas sales.
It will be an interesting few weeks.
As someone mentioned earlier - high risk: high reward - and i'm happy with the risk!
GLA.
Stephen11.
Thanks Neil,
Yes, hopefully GDR can get some sort of positive news out - it’s certainly due on multiple fronts!….the SP has been highly influenced by sentiment in the past and we haven’t had much to smile about in the last 3 months - come on James C…pull a rabbit out of your hat 🎩.
Apologies for this short non-GDR related question comrades.
Hi neil777,
The HE1 board has been infiltrated by a bunch of mad men.
Short question?
My understanding was that the next RNS would be a more detailed lab appraisal above, confirming the find?
Is this still the case, and if so what timescales are we looking at?
Best wishes,
Stephen11.
I wish you the best of luck with emailing Walbrook Patty.
The cynic in me would say that you will receive a very generic, non-specific reply (like a politician trying to worm out of a question), although i hope you prove me wrong.
*Key targets set at the Nov 23 Investormeetcompany Meeting with outcomes as of today 13/03/24*
**Hearing Loss (AHIL) - MT-RNR1**
TARGET: In Oct 2023 software and training materials for the MT-RNR1 test were translated into several foreign languages (this had not been the case under David Budd's tenure). James Cheek reported that he expected to see orders coming in from European countries in the month of December 2023.
-RESULT: No firm orders/sales figures have been released to date. The RNS of 20th Dec 2023 states initial orders were sent to 6 countries, but only for promotion and in-country evaluation processes
TARGET : James is actively speaking to those in charge of NHS budgets in regards to getting the MT-RNR1 test commissioned nationally in the UK. JC states he has 100% clarity that special commissioning for the hearing loss test will happen.
RESULT: No more word on specialist commissioning as yet.
TARGET: JC is speaking to regional innovation networks (e.g., in Scotland and Wales) and various health trusts to gain commercial traction in Dec 23 and Jan 24. JC states - revenue and commercial traction for the hearing loss test imminent - as soon as Dec this year and Jan next year
RESULT: The Royal Sussex County Hospital, Brighton was announced via RNS on 4th Dec 2023 - no other health trusts or sales have been announced since.
TARGET: In discussions the FDA have been incredible supportive about the MT-RNR1 test and JC reported that a deal with an American partner could be announced Dec 23 or Jan 24. JC states: contracts being drawn up with potential partners who can help with the FDA application for the hearing loss product in a cost effective manner.
RESULT: No word as yet on FDA or the possibility of American partners.
TARGET: NICE full validation for the MTRNR1 is being hindered by the EVO procedure and not the product - news due Jan 2024, states JC.
RESULT: No word as yet.
**Stroke Test - CYP2CI9**
TARGET: The Manchester Health Trust will be starting to use the CYP2CI9 routinely in late Dec 23 or early Jan 24.
RESULT: No RNS info to confirm this has taken place.
TARGET: GDR are actively speaking to other health trusts around the UK and have garnered a considerable amount of interest.
RESULT: Haven't heard of anymore UK Trusts adopting the CYP2CI9 test as yet.
TARGET: The CYP2CI9 test is being actively marketed around Europe as a research only product - to create interest around the various countries and to create early commercial traction.
RESULT: No proof of concrete sales/orders as yet.
TARGET: NICE Review of the CYP2CI9 - due Jan 2024
RESULT: No word on this as yet.
TARGET: More grant funding is also a possibility e.g., through MedTech etc.
RESULT: No more word on this
**Conclusions** Now I am a pretty easy going guy and wasn't thinking that all these points would go to plan, although I expected some progress and much more transparent info sharing. The silence is deafening! Hope for go
Https://www.lse.co.uk/rns/HE1/itumbula-west-1-well-flows-helium47-to-surface-h3ozbl2v33bohu1.html
Highlights:
· Itumbula West-1 well has successfully completed all wireline logging and drill stem testing ("DST") operations
· The well successfully flowed a high concentration of helium to surface from Basement, at a measured concentration up to 4.7% helium
In the details section the text further states:
Despite having an accurate, independent field PVT laboratory on site, the Company has collected duplicate samples where possible, and these will be sent to a second laboratory for independent verification.
My question to this forum is: How long will this SECOND LAB TEST FOR INDEPENDENT VERIFICATION take before we get an RNS?....should be a real positive!
Thanks in advance,
Stephen11.